358 related articles for article (PubMed ID: 18483339)
1. Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus.
Sadeghi S; Bain CJ; Pandeya N; Webb PM; Green AC; Whiteman DC;
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1169-78. PubMed ID: 18483339
[TBL] [Abstract][Full Text] [Related]
2. Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus.
Pandeya N; Williams G; Green AC; Webb PM; Whiteman DC;
Gastroenterology; 2009 Apr; 136(4):1215-24, e1-2. PubMed ID: 19250648
[TBL] [Abstract][Full Text] [Related]
3. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
Farrow DC; Vaughan TL; Hansten PD; Stanford JL; Risch HA; Gammon MD; Chow WH; Dubrow R; Ahsan H; Mayne ST; Schoenberg JB; West AB; Rotterdam H; Fraumeni JF; Blot WJ
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):97-102. PubMed ID: 9488582
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County.
Duan L; Wu AH; Sullivan-Halley J; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):126-34. PubMed ID: 18187391
[TBL] [Abstract][Full Text] [Related]
5. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers.
Whiteman DC; Parmar P; Fahey P; Moore SP; Stark M; Zhao ZZ; Montgomery GW; Green AC; Hayward NK; Webb PM;
Gastroenterology; 2010 Jul; 139(1):73-83; quiz e11-2. PubMed ID: 20399210
[TBL] [Abstract][Full Text] [Related]
6. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
[TBL] [Abstract][Full Text] [Related]
7. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence.
Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; Comber H; McGuigan J; Reynolds JV; Murray LJ
Cancer Res; 2006 May; 66(9):4975-82. PubMed ID: 16651456
[TBL] [Abstract][Full Text] [Related]
9. Associations of duration, intensity, and quantity of smoking with adenocarcinoma and squamous cell carcinoma of the esophagus.
Pandeya N; Williams GM; Sadhegi S; Green AC; Webb PM; Whiteman DC
Am J Epidemiol; 2008 Jul; 168(1):105-14. PubMed ID: 18483122
[TBL] [Abstract][Full Text] [Related]
10. Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?
Pandeya N; Webb PM; Sadeghi S; Green AC; Whiteman DC;
Gut; 2010 Jan; 59(1):31-8. PubMed ID: 19875392
[TBL] [Abstract][Full Text] [Related]
11. Association between ambient ultraviolet radiation and risk of esophageal cancer.
Tran B; Lucas R; Kimlin M; Whiteman D; Neale R;
Am J Gastroenterol; 2012 Dec; 107(12):1803-13. PubMed ID: 23032986
[TBL] [Abstract][Full Text] [Related]
12. Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
Lindblad M; Lagergren J; García Rodríguez LA
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):444-50. PubMed ID: 15734971
[TBL] [Abstract][Full Text] [Related]
13. Cancers of the esophagus and carbonated beverage consumption: a population-based case-control study.
Ibiebele TI; Hughes MC; O'Rourke P; Webb PM; Whiteman DC;
Cancer Causes Control; 2008 Aug; 19(6):577-84. PubMed ID: 18231869
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.
Vaughan TL; Kristal AR; Blount PL; Levine DS; Galipeau PC; Prevo LJ; Sanchez CA; Rabinovitch PS; Reid BJ
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):745-52. PubMed ID: 12163328
[TBL] [Abstract][Full Text] [Related]
15. Regular use of analgesic drugs and ovarian cancer risk.
Moysich KB; Mettlin C; Piver MS; Natarajan N; Menezes RJ; Swede H
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):903-6. PubMed ID: 11489759
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal anti-inflammatory drugs and subsite-specific colorectal cancer incidence in the Iowa women's health study.
Mahipal A; Anderson KE; Limburg PJ; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1785-90. PubMed ID: 17035383
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal anti-inflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin.
Butler GJ; Neale R; Green AC; Pandeya N; Whiteman DC
J Am Acad Dermatol; 2005 Dec; 53(6):966-72. PubMed ID: 16310056
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
Platz EA; Rohrmann S; Pearson JD; Corrada MM; Watson DJ; De Marzo AM; Landis PK; Metter EJ; Carter HB
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):390-6. PubMed ID: 15734963
[TBL] [Abstract][Full Text] [Related]
19. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
Bardia A; Ebbert JO; Vierkant RA; Limburg PJ; Anderson K; Wang AH; Olson JE; Vachon CM; Cerhan JR
J Natl Cancer Inst; 2007 Jun; 99(11):881-9. PubMed ID: 17551148
[TBL] [Abstract][Full Text] [Related]
20. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.
Lagergren J; Bergström R; Lindgren A; Nyrén O
N Engl J Med; 1999 Mar; 340(11):825-31. PubMed ID: 10080844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
